No Strong Benefit of Long-term Anticoagulation in Secondary AF No Strong Benefit of Long-term Anticoagulation in Secondary AF

A preliminary study suggests little benefit on stroke reduction and a suggestion of increased bleeding from long-term anticoagulation in transient AF secondary to ACS, sepsis, or lung disease.Medscape Medical News

Source: Medscape Cardiology Headlines - October 16, 2017 Category: Cardiology Tags: Cardiology News Source Type: news